[Results of therapy of active chronic hepatopathies with 6-mercaptopurine].
D000293:Adolescent; D000328:Adult; D000963:Antimetabolites / Q000627:therapeutic use*; D001375:Azaguanine / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002908:Chronic Disease; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006505:Hepatitis / Q000188:drug therapy*; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy*; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use*; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D013866:Thioguanine / Q000627:therapeutic use
D000963:Antimetabolites; D003520:Cyclophosphamide; D015122:Mercaptopurine; D013866:Thioguanine; D001379:Azathioprine; D001375:Azaguanine; D011241:Prednisone
Ergebnisse der Therapie aktiver chronischer Hepatophathien mit 6-Merkaptopurin.